Stockreport

Repligen higher as HSBC initiates at Buy on growth prospects [Seeking Alpha]

Repligen Corporation  (RGEN) 
Last repligen corporation earnings: 2/20 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: repligen.com/investors
PDF and a target price of $150 per share, citing the life sciences company's growth prospects. Analyst Yessica Sanchez argued that Waltham, Massachusetts-based Repligen ( [Read more]